SynAct Pharma AB · OMXSTO:SYNACT
Quantass ApS bought 3,529 SynAct Pharma AB shares (MAR article 19 notification)
Traded Dec 17, 2025 · Filed Dec 22, 2025 · Read by 6ix Oct 14, 2026
On Dec 17, 2025, Quantass ApS (Chief Executive Officer (CEO)/Managing Directory) bought 3,529 SynAct Pharma AB shares at SEK 20.24 for SEK 71,429. Filed Dec 22, 2025 (MAR article 19 notification).
- Bought
- 3,529 shares
- Price
- SEK 20.24
- Value
- SEK 71,429
- Role
- Chief Executive Officer (CEO)/Managing Directory
The register entry
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Dec 17, 2025 | SynAct Pharma AB | Buy | 3,529 | SEK 20.24 | Direct |
Source
View original at Finansinspektionen
Related
- SynAct Pharma AB
- Quantass ApS
- SynAct Pharma AB shareholders
- MAR article 19 notification · Quantass ApS · Nov 18, 2026
- MAR article 19 notification · Quantass ApS · Sep 7, 2026
- MAR article 19 notification · Quantass ApS · Mar 9, 2026
- MAR article 19 notification · TJ Biotech Holding ApS · Sep 7, 2026
- MAR article 19 notification · Anders Kronborg · Mar 10, 2026
- MAR article 19 notification · Mads Liebach Bjerregaard · Mar 9, 2026
- MAR article 19 notification · Boesen Biotech ApS · Mar 6, 2026
- MAR article 19 notification · TJ Biotech Holding ApS · Dec 31, 2025